Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Injection in Epicardial Fat Pads for AF After CABG
NCT02982434Phase 2Unknown
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Sep 2016
- Primary completion
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of neuronox in Atrial fibrillation (AFib) (2 arms), sponsored by E. Meshalkin National Medical Research Centre. Primary endpoint: Freedom from any atrial tachyarrhythmias at 12 months. Status: unknown.
02
Drugs
neuronox
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02982434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02982434.